Health Care: Drugs

Durata Therapeutics Inc (DRTX: NASDAQ)

$12.8 n/a | n/a%
07/29/14 - 03:59 PM ET
Company Balance Sheet
Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 36.85M 32.26M 11.49M
Receivables 0.00 0.00 0.00
Inventories 0.00 0.00 0.00
Other Current Assets 0.00 0.00 0.00
Total Current Assets 63.10M 51.20M 12.48M
Property, Plant & Equipment, Gross 1.16M 996.02K 0.00
Accumulated Depreciation & Depletion 267.00K 14.60K 0.00
Property, Plant & Equipment, Net 897.00K 981.42K 0.00
Intangibles 0.00 0.00 0.00
Other Non-Current Assets 30.34M 28.56M 15.33M
Total Non-Current Assets 37.04M 35.35M 21.14M
Liabilities & Shareholder Equity
Total Assets 100.14M 86.55M 33.62M
Accounts Payable 5.28M 8.62M 1.96M
Short Term Debt 0.00 0.00 0.00
Other Current Liabilities 1.61M 2.28M 0.00
Total Current Liabilities 14.00M 21.50M 3.33M
Long Term Debt 25.00M 0.00 0.00
Deferred Income Taxes 0.00 0.00 0.00
Other Non-Current Liabilities 22.56M 21.17M 18.74M
Minority Interest 0.00 0.00 0.00
Total Non-Current Liabilities 47.56M 21.17M 24.74M
Total Liabilities 61.56M 42.68M 28.06M
Preferred Stock Equity 0.00 0.00 491.98K
Common Stock Equity 38.58M 43.87M 5.07M
Common Par 266.00K 183.60K 625.00
Additional Paid In Capital 207.75M 150.99M 49.83M
Cumulative Translation Adjustment 0.00 0.00 0.00
Retained Earnings 0.00 0.00 0.00
Treasury Stock 0.00 0.00 0.00
Other Equity Adjustments -169.44M -107.30M -44.76M
Total Capitalization 63.58M 43.87M 5.56M
Total Equity 38.58M 43.87M 5.56M
Total Liabilities & Stock Equity 100.14M 86.55M 33.62M
Total Common Shares Outstanding 26.63M 18.36M 17.24M
Preferred Shares 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00
Basic Weighted Shares Outstanding 24.22M 8.36M 9.71M
Diluted Weighted Shares Outstanding 24.22M 8.36M 9.71M
Number of Employees 67 39 NA
Number of Part-Time Employees 1 0 NA

Portfolios with DRTX

Latest DRTX Headlines from TheStreet

More Financial News for DRTX

Press Releases for DRTX

See All Press Releases

Partner Headlines for DRTX

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter